Project Grant R43AI152650
Award Date 3/2/21
Completion Date 2/29/24
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Luis Obispo, CA 93407, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $165,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Tufts University School of Medicine to develop an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the bacterium that causes Lyme disease. The project, running from July 1, 2025 to June 30, 2027, aims to create a high-efficiency transposon insertional mutagenesis system...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $207,262 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in Saint Louis to develop an mRNA vaccine against Bourbon virus, an emerging tick-borne pathogen. The primary objective is to evaluate the efficacy of the mRNA vaccine in a mouse model and determine its mechanism of action. A secondary objective is to test different viral antigens and...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $417,845 to the University of Nebraska Medical Center (UNMC) to adapt an in vitro human skin model for tick feeding to study transmission and colonization of the Lyme disease pathogen Borrelia burgdorferi. The 2-year project aims to: 1) Increase tick feeding efficiency and demonstrate transmission/acquisition of...
- This Project Grant award of $457,875.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) supports research to elucidate how the alternative sigma factor RpoS regulates gene expression in Borrelia burgdorferi and contributes to the persistence of the Lyme disease spirochete in the mammalian host. The key objectives are to 1) interrogate individual RpoS-regulated genes throughout the course...
- This federal Project Grant award for $640,129 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to decipher the regulatory networks of Borrelia burgdorferi (the bacteria that causes Lyme disease) as it transitions between tick vectors and mammalian hosts. The research aims to understand how the RpoS regulatory pathway controls gene expression to enable B. burgdorferi's dual-host lifestyle. Key objectives...
- The U.S. Department of Agriculture's (USDA) National Institute of Food and Agriculture (NIFA) awarded a $800,000 Project Grant under the Agriculture and Food Research Initiative (AFRI) program to Washington State University (WSU). The grant aims to develop a vaccine against anaplasmosis, a prevalent tick-borne infection in cattle that causes significant morbidity and an estimated $300 million in annual economic losses in the U.S. The project will test the protective capacity of outer membrane...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is providing $3,315,179 to Tufts University School of Medicine in Boston, Massachusetts to conduct research on the microbial determinants of excessive inflammation and severe Lyme disease. The research aims to systematically delineate the immunogenic lipoproteins of the Borrelia burgdorferi bacterium and ascertain their...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $423,106 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Texas A&M AgriLife Research. This 2-year project, with a start date of August 1, 2025, aims to characterize the roles of tick inhibitors of metalloproteases in the transmission of the Lyme disease agent by blacklegged nymphal ticks. The research will involve unveiling the protease inhibition profiles of these tick...
- This $431,750 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), will fund a 2-year research project to develop a "Basic Immunological Toolbox for Genus Peromyscus, Infection Tolerant Reservoirs of Zoonotic Agents". The project will focus on the white-footed deermouse (Peromyscus leucopus) and deer mouse (Peromyscus maniculatus), which are natural...
- The U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) awarded a $599,455 Project Grant under the Small Business Innovation Research (SBIR) Program (CFDA 10.212) to VST LLC (DBA Medgene Labs) located in Brookings, SD. The purpose of this 2-year grant is to develop the first U.S.-based vaccine against the invasive Asian Longhorned Tick, which poses a major threat to animal health and productivity in cattle and other livestock. The vaccine will be...